Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 476-479

  Harrer, Ellen ^b   Harrer, Thomas ^b   Barbosa, Peter ^b   Feinberg, Mark ^b   Paul Johnson, R ^b   Buchbinder, Susan ^b   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DERIVATIVE; DIDANOSINE; HLA A2 ANTIGEN; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; DRUG RESISTANCE; EPITOPE MAPPING; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; T LYMPHOCYTE ACTIVATION; VIRUS MUTATION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BASE SEQUENCE; CONSERVED SEQUENCE; DEOXYCYTIDINE; DIDANOSINE; DNA PRIMERS; DRUG RESISTANCE, MICROBIAL; EPITOPES; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HLA-A2 ANTIGEN; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; T-LYMPHOCYTES, CYTOTOXIC; ZALCITABINE;

EID: 0030071441     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.476     Document Type: Article

References (15)

1. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
2. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with longterm nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
3. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
4. Johnson RP, Trocha A, Buchanan TM, Walker BD. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J Exp Med 1992;175:961-71.
5. Piatak M Jr, Luk KC, Williams B, Lifson JD. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 1993;14:70-81.
6. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993;75:693-708 (erratum, 1994;76:following 410).
7. Boyer PL, Ferris AL, Hughes SH. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type I. J Virol 1992;66:1031-9.
8. D'Aquila RT. HIV-1 drug resistence: molecular pathogenesis and laboratory monitoring. Clin Lab Med 1994;14:393-422.
9. Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type I resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci USA 1993;90:5653-6.
10. Meyers G, Berzofsky JA, Korber B, Smith RF, Pailakis GN. Human retroviruses and AIDS 1993: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics, Los Alamos National Laboratory, 1993; publication no. LA-UR 94-4171.
11. Larder BA, Kellam P, Kemp SD. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 1993;365:451-3.
12. Boucher CA, Schumann R, Nijhuis M, et al. Acquisition of 3TC resistance mutations coincides with an increase in viral load [abstract]. In: Program and abstracts: 1st National Conference on Human Retroviruses and Related Infections. Washington, DC: American Society for Microbiology, 1993.
13. Balzarini J, Karlsson A, Perez-Perez MJ, Camarasa MJ, Tarpley WG, De Clercq E. Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy. J Virol 1993;67:5353-9.
14. Moskophides D, Zinkernagel RM. Immunobiology of CTL escape mutants of LCMV. J Virol 1995;69:2187-93.
15. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc Natl Acad Sci USA 1991;88:11276-80.